BA
INFI

BlackRock Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

BlackRock Advisors’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$146K Sell
108,367
-4,342
-4% -$5.67K ﹤0.01% 2867
2016
Q3 		$176K Buy
112,709
+2,199
+2% +$3.38K ﹤0.01% 2750
2016
Q2 		$147K Sell
110,510
-394,270
-78% -$1.84M ﹤0.01% 2775
2016
Q1 		$2.66M Sell
504,780
-82,209
-14% -$503K ﹤0.01% 1313
2015
Q4 		$4.61M Sell
586,989
-32,696
-5% -$281K ﹤0.01% 1125
2015
Q3 		$5.24M Buy
619,685
+8,007
+1% +$73.9K 0.01% 1075
2015
Q2 		$6.7M Sell
611,678
-46,419
-7% -$596K 0.01% 894
2015
Q1 		$9.2M Buy
658,097
+12,467
+2% +$191K 0.01% 811
2014
Q4 		$10.9M Buy
645,630
+176,187
+38% +$2.57M 0.01% 753
2014
Q3 		$6.3M Sell
469,443
-41,076
-8% -$489K 0.01% 915
2014
Q2 		$6.5M Sell
510,519
-5,218
-1% -$54.4K 0.01% 902
2014
Q1 		$6.13M Sell
515,737
-10,444
-2% -$140K 0.01% 922
2013
Q4 		$7.27M Sell
526,181
-641,929
-55% -$9.07M 0.01% 897
2013
Q3 		$20.4M Sell
1,168,110
-118,928
-9% -$2.28M 0.02% 553
2013
Q2 		$20.8M Buy
+1,287,038
New +$39.8M 0.02% 531

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Advisors's INFI Position: Q4 2016 in Review

BlackRock Advisors reduced its Infinity Pharmaceuticals, Inc. (INFI) stake by 3.9% in Q4 2016, selling an estimated $5.67K and leaving 108,367 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #2867.

BlackRock Advisors first reported a position in INFI in Q2 2013 and has held it in 15 quarters since. The position peaked at $20.8M in Q2 2013. 94 funds tracked by Wall St. Rank hold INFI as of Q4 2016.

  • BlackRock Advisors held 108,367 shares of Infinity Pharmaceuticals, Inc. worth $146K as of Q4 2016.
  • BlackRock Advisors sold 4,342 Infinity Pharmaceuticals, Inc. shares in Q4 2016, an estimated $5.67K.
  • Infinity Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2867 holding.
  • BlackRock Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Infinity Pharmaceuticals, Inc. position peaked at $20.8M in Q2 2013.
  • 94 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.